Zydus to launch Semaglutide Injection in India, featuring a unique reusable pen for improved diabetes and obesity management.

Zydus Lifesciences will roll out generic semaglutide injections in India post-patent expiry, using a reusable single-pen ...

Zydus plans to launch its diabetes and obesity injection using a reusable adjustable pen device after patent expiry, as more Indian drugmakers enter the market.

DCGI had earlier provided its approval for manufacturing and marketing Semaglutide injection for the treatment of Type 2 ...

One of the standout features of Zydus' semaglutide offering is its unique, indigenously developed drug delivery system ...

A daily pill version of Wegovy worked just as well as the weekly shot in clinical trials. If approved by the FDA, the pills could be a nice option for people with obesity and needle phobias. The pill ...

Zydus has received regulatory approval from the Drug Controller General of India (DCGI) to market and manufacture semaglutide ...

With multiple launches lined up for March, companies are betting on device innovation, brand strategy, and patient-support ...

Zydus plans to launch innovative semaglutide injection in India on day 1 of patent expiry: Our Bureau, Mumbai Thursday, February 26, 2026, 11:30 Hrs [IST] Zydus Lifesciences Limit ...

Although Semaglutide injections are an effective treatment for obesity management it is not suitable for all. Those that do not have a BMI over 30 or find the high price point problematic often seek ...

Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...

Ahmedabad: Zydus Lifesciences Limited said it plans to launch semaglutide injection in India under the brand names Semaglyn, Mashema and Alterme after.